ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 997,15
0,17%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) Actualités

IGMS IGM Biosciences Inc

10,07
0,64 (6,79%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IGM Biosciences Inc IGMS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,64 6,79% 10,07 23:55:51
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,73 9,72 10,19 10,07 9,43
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202414:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
10/4/202413:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
07/3/202422:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:10EDGAR2Form 8-K - Current report
07/3/202422:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
06/3/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
08/1/202415:00EDGAR2Form 8-K - Current report
04/1/202402:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202413:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
16/12/202301:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:36EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:33EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:30EDGAR2Form 144 - Report of proposed sale of securities
13/12/202323:27EDGAR2Form 144 - Report of proposed sale of securities
08/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
02/12/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202311:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
30/11/202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202302:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/11/202308:48PRNUSMedivir to present at the Erik Penser Bank Company Event
13/11/202323:08EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
13/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
06/10/202301:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202301:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202313:29PRNUSFostrox + Lenvima continues to show promising tumor control..
04/10/202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202301:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:14EDGAR2Form 8-K - Current report
03/10/202322:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
02/10/202322:27EDGAR2Form 144 - Report of proposed sale of securities
06/9/202313:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
03/8/202322:13EDGAR2Form 8-K - Current report
03/8/202322:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
03/8/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/7/202322:13EDGAR2Form SC 13D/A - General statement of acquisition of..

Dernières Valeurs Consultées

NASDAQ
IGMS
IGM Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés